Fain Eric S

Director Fain Eric S bought 20,000 shares of OBIO at $4.13 on 2026-05-14; holding reaches 91.7K shares. Stock at $4.00, down -26.2% from 52-week high.

Director Fain Eric S purchased 20,000 shares at $4.13, increasing his stake from 71.7K to 91.7K shares (+27.9%). The transaction occurs with the stock trading at $4.00, substantially below its 52-week high of $5.42 and down -12.7% over the prior 30 days. His prior buy at this ticker on 2025-08-25 showed a 90-day return of +73.6%, which was well-timed. Additionally, 2 other insiders bought within the past 14 days, creating a cluster pattern of insider purchases. The company reported revenue of $110.0K in its latest quarter but net income of $-20.7M, with negative full-year profitability, setting this accumulation against a financially distressed backdrop.

Director Fain Eric S bought 5,760 shares of OBIO at $2.61; 3 other insiders also bought in past 14 days

Eric S Fain, a director, purchased 5,760 shares at $2.61 on 2025-08-25, increasing his holdings by 8.7% to 71,709 shares. This purchase occurs as part of a cluster pattern, with 3 other insiders also buying within the past 14 days. The timing is notable given that the stock has declined -21.0% over the past 30 days and -61.2% from its 52-week high of $6.70. The company faces substantial headwinds: it reported negative net income of $-19,363,000.00 in its latest period, contracted -4.4% year-over-year in annual revenue, and generated only $836,000.00 in quarterly revenue against a $140.3M market cap. The coordinated insider buying activity against a backdrop of severe financial losses and recent sharp price declines is a factual pattern worth tracking.